1. Mitochondrial DNA plasticity is an essential inducer of tumorigenesis
   W T Y Lee et al, 2016, Cell Death Discovery CrossRef
2. Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia
   Vasiliki Papadopoulou et al, 2016, Leukemia & Lymphoma CrossRef
3. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function
   Alessia Varone et al, 2021, Cell Communication and Signaling CrossRef
4. DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
   Benjamin Lebecque et al, 2021, Cancers CrossRef
5. The role of Src homology region 2 domain-containing phosphatase-1 hypermethylation in the classification of patients with myelodysplastic syndromes and its association with signal transducer and activator of transcription 3 phosphorylation in skm-1 cells
   Ying Han et al, 2021, Journal of International Medical Research CrossRef
6. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
   Hamid Ali Nagi Al-Jamal et al, 2015, BMC Cancer CrossRef
7. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
   Elisa Pardella et al, 2020, Cancers CrossRef
8. Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
   Steffen Koschmieder et al, 2018, Seminars in Cancer Biology CrossRef
9. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia
   Xiaokun Zhang et al, 2017, British Journal of Haematology CrossRef
10. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells
    Yinghua Li et al, 2017, Leukemia Research CrossRef
11. SHP-1: the next checkpoint target for cancer immunotherapy?
    H. Angharad Watson et al, 2016, Biochemical Society Transactions CrossRef
12. Shp1 in Solid Cancers and Their Therapy
    Alessia Varone et al, 2020, Frontiers in Oncology CrossRef
13. Epithelial Src homology region 2 domain–containing phosphatase‐1 restrains intestinal growth, secretory cell differentiation, and tumorigenesis
    Caroline Leblanc et al, 2017, The FASEB Journal CrossRef
14. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
    Liang-Zhi Wen et al, 2018, Cancer Research CrossRef
15. Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020)
    Jingwei Wu et al, 2021, Current Medicinal Chemistry CrossRef
16. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
    De-long Wu et al, 2022, European Journal of Medical Research CrossRef
17. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
    Masumeh Maleki Behzad et al, 2018, Biochemical Genetics CrossRef
18. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
    Lenka Kalinkova et al, 2022, International Journal of Molecular Sciences CrossRef
19. DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Geórgia Muccillo Dexheimer et al, 2017, Disease Markers CrossRef
20. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
    Bob Meeusen et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
21. Synthesis and Biological Evaluation of 3-Amino-4,4-Dimethyl Lithocholic Acid Derivatives as Novel, Selective, and Cellularly Active Allosteric SHP1 Activators
    Huiqing Chen et al, 2023, Molecules CrossRef
22. Implication of Protein Tyrosine Phosphatase Shp-1 In Cancer-Related Signaling Pathways
    Yadhu Sharma et al, 2016, Future Oncology CrossRef
23. Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia
    Jing-Dong Zhou et al, 2015, Biochemical and Biophysical Research Communications CrossRef
24. Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3
    Houcai Wang et al, 2016, Oncotarget CrossRef
25. RETRACTED ARTICLE: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia
    Zhu Xishan et al, 2015, Scientific Reports CrossRef
26. Mtss1 is a critical epigenetically regulated tumor suppressor in CML
    M Schemionek et al, 2016, Leukemia CrossRef